The current valuation score of LifeVantage Corp is 8.52, ranking 89 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 13.20, which is 564.13% below the recent high of 87.64 and 828.32% above the recent low of -96.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.